Hyderabad: Hyderabad-based pharmaceutical retailer Medplus Health Services Ltd has repaired the ribbon price of Rs 780-796 per share nominal value of Rs 2 for the initial public offer around Rs 1,398 Crore.
The IPO, which includes fresh problems from shares collected to Rs 600 Crore and offers for sale up to RS 798.3 Crore, will be opened on December 13 and close on December 15.
Investors can bid at least 18 equity shares and in its multiples.
Offers for anchor investors will be opened on December 10.
Stocks are proposed to be included in BSE and NSE.
Offers for sale will see investors such as the functions of the Shares SELLESAI Worth RS 623 Crore, SS Pharma LLC (RS 107 Crore), Shore Pharma LLC (RS 32 Crore), Natco Pharma (Rs 10 Crore), among others.
Medplus, which operates the second largest pharmaceutical chain in India with more than 2,165 outlets in Tier-1 to Tier-4 centers in seven states – Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West West, Maharashtra, and Odisha, will Take advantage of net results of new problems to fund the requirements for working capital of their subsidiaries and for the purposes of public companies.
Medplus, which was founded in 2006, relied on the increase in sales and the number of stores to increase growth, said the founder, managing director and CEO of Gangadi Madhukar Reddy on Tuesday, added that he added about 700 stores in the middle of Covid.
-19.
He also shows that Medplus also focuses on boosting sales from private label goods, which stands around 12% of total income.
Revenue from online sales is currently standing around 9%, he added.